UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 113

Sortiert nach

β-Catenin is required for the tumorigenic behavior of triple-negative breast cancer cells

PloS one, 2015-02, Vol.10 (2), p.e0117097-e0117097

2015

Link zum Volltext

Verfügbarkeit prüfen

A Wnt-ow of opportunity: targeting the Wnt/beta-catenin pathway in breast cancer

Current drug targets, 2010-09, Vol.11 (9), p.1074

2010

Link zum Volltext

Verfügbarkeit prüfen

Regulation of Tcf7l1 DNA Binding and Protein Stability as Principal Mechanisms of Wnt/β-Catenin Signaling

Cell reports (Cambridge), 2013-07, Vol.4 (1), p.1-9

2013

Link zum Volltext

Verfügbarkeit prüfen

Exploiting APC function as a novel cancer therapy

Current drug targets, 2014-01, Vol.15 (1), p.90

2014

Link zum Volltext

Verfügbarkeit prüfen

Hsp70 exerts oncogenic activity in the Apc mutant Min mouse model

Carcinogenesis (New York), 2016-07, Vol.37 (7), p.731-739

2016

Link zum Volltext

Verfügbarkeit prüfen

Cohort profile: the ChicagO Multiethnic Prevention and Surveillance Study (COMPASS)

BMJ open, 2020-09, Vol.10 (9), p.e038481-e038481

2020

Link zum Volltext

Verfügbarkeit prüfen

APC/β-catenin-rich complexes at membrane protrusions regulate mammary tumor cell migration and mesenchymal morphology

BMC cancer, 2013-01, Vol.13 (1), p.12-12, Article 12

2013

Link zum Volltext

Verfügbarkeit prüfen

Apc mutation enhances PyMT-induced mammary tumorigenesis

PloS one, 2011-12, Vol.6 (12), p.e29339

2011

Link zum Volltext

Verfügbarkeit prüfen

Wnt/β-Catenin Pathway Activation Is Enriched in Basal-Like Breast Cancers and Predicts Poor Outcome

The American journal of pathology, 2010-06, Vol.176 (6), p.2911-2920

2010

Link zum Volltext

Verfügbarkeit prüfen

Targeting the Wnt Pathway in Cancer

1. Aufl., 2011

Link zum Volltext

Verfügbarkeit prüfen

Racial disparities in omission of oncotype DX but no racial disparities in chemotherapy receipt following completed oncotype DX test results

Breast cancer research and treatment, 2018-02, Vol.168 (1), p.207-220

2018

Link zum Volltext

Verfügbarkeit prüfen

β-catenin regulates c-Myc and CDKN1A expression in breast cancer cells

Molecular carcinogenesis, 2016-05, Vol.55 (5), p.431-439

2016

Link zum Volltext

Verfügbarkeit prüfen

[beta]-catenin regulates c-Myc and CDKN1A expression in breast cancer cells

Molecular carcinogenesis, 2016-05, Vol.55 (5), p.431

2016

Link zum Volltext

Verfügbarkeit prüfen

The APC tumor suppressor is required for epithelial cell polarization and three-dimensional morphogenesis

Biochimica et biophysica acta, 2015-03, Vol.1853 (3), p.711-723

2015

Link zum Volltext

Verfügbarkeit prüfen

872 HSP70 Is Required for Loss of Heterozygosity in the ApcMin/+ Model of Colorectal Cancer

Gastroenterology (New York, N.Y. 1943), 2014-05, Vol.146 (5), p.S-151-S-152

2014

Link zum Volltext

Verfügbarkeit prüfen

A p53-regulated apoptotic gene signature predicts treatment response and outcome in pediatric acute lymphoblastic leukemia

Cancer management and research, 2017-01, Vol.9, p.397-410

2017

Link zum Volltext

Verfügbarkeit prüfen

The APC tumor suppressor is required for epithelial integrity in the mouse mammary gland

Journal of cellular physiology, 2009-08, Vol.220 (2), p.319-331

2009

Link zum Volltext

Verfügbarkeit prüfen

The Ron receptor tyrosine kinase is not required for adenoma formation in Apc(Min/+) mice

Molecular carcinogenesis, 2009-11, Vol.48 (11), p.995-1004

2009

Link zum Volltext

Verfügbarkeit prüfen

Janet Davison Rowley: In Memoriam (1925–2013)

Cancer research (Chicago, Ill.), 2014-04, Vol.74 (8), p.2135-2137

2014

Link zum Volltext

Verfügbarkeit prüfen

Janet Davison Rowley (1925–2013)

Cancer cell, 2014-01, Vol.25 (1), p.1-2

2014

Link zum Volltext

Verfügbarkeit prüfen

Abstract 499: β-catenin is required for triple-negative breast tumorigenesis

Cancer research (Chicago, Ill.), 2013-04, Vol.73 (8_Supplement), p.499-499

2013

Link zum Volltext

Verfügbarkeit prüfen

[beta]-Catenin Is Required for the Tumorigenic Behavior of Triple-Negative Breast Cancer Cells

PloS one, 2015-02, Vol.10 (2), p.e0117097

2015

Link zum Volltext

Verfügbarkeit prüfen

Abstract 4327: Loss of the APC tumor suppressor alters breast cancer cell migration and invasion

Cancer research (Chicago, Ill.), 2012-04, Vol.72 (8_Supplement), p.4327-4327

2012

Link zum Volltext

Verfügbarkeit prüfen

APC/[beta]-catenin-rich complexes at membrane protrusions regulate mammary tumor cell migration and mesenchymal morphology

BMC cancer, 2013-01, Vol.13 (1)

2013

Link zum Volltext

Verfügbarkeit prüfen

β-catenin regulates c-Myc and CDKN1A expression in breast cancer cells: β-CATENIN REGULATES c-Myc AND CDKN1A

Molecular carcinogenesis, 2016-05, Vol.55 (5), p.431-439

2016

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 113

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(107)
Mit Volltextzugriff
(108)

Publikationsform

Sprache

Englisch
(113)
Japanisch
(11)
Deutsch
(1)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

β-Catenin is required for the tumorigenic behavior of triple-negative breast cancer cells

A Wnt-ow of opportunity: targeting the Wnt/beta-catenin pathway in breast cancer

Regulation of Tcf7l1 DNA Binding and Protein Stability as Principal Mechanisms of Wnt/β-Catenin Signaling

Exploiting APC function as a novel cancer therapy

Hsp70 exerts oncogenic activity in the Apc mutant Min mouse model

Cohort profile: the ChicagO Multiethnic Prevention and Surveillance Study (COMPASS)

APC/β-catenin-rich complexes at membrane protrusions regulate mammary tumor cell migration and mesenchymal morphology

Apc mutation enhances PyMT-induced mammary tumorigenesis

Wnt/β-Catenin Pathway Activation Is Enriched in Basal-Like Breast Cancers and Predicts Poor Outcome

Targeting the Wnt Pathway in Cancer

Racial disparities in omission of oncotype DX but no racial disparities in chemotherapy receipt following completed oncotype DX test results

β-catenin regulates c-Myc and CDKN1A expression in breast cancer cells

[beta]-catenin regulates c-Myc and CDKN1A expression in breast cancer cells

The APC tumor suppressor is required for epithelial cell polarization and three-dimensional morphogenesis

872 HSP70 Is Required for Loss of Heterozygosity in the ApcMin/+ Model of Colorectal Cancer

A p53-regulated apoptotic gene signature predicts treatment response and outcome in pediatric acute lymphoblastic leukemia

The APC tumor suppressor is required for epithelial integrity in the mouse mammary gland

The Ron receptor tyrosine kinase is not required for adenoma formation in Apc(Min/+) mice

Janet Davison Rowley: In Memoriam (1925–2013)

Janet Davison Rowley (1925–2013)

Abstract 499: β-catenin is required for triple-negative breast tumorigenesis

[beta]-Catenin Is Required for the Tumorigenic Behavior of Triple-Negative Breast Cancer Cells

Abstract 4327: Loss of the APC tumor suppressor alters breast cancer cell migration and invasion

APC/[beta]-catenin-rich complexes at membrane protrusions regulate mammary tumor cell migration and mesenchymal morphology

β-catenin regulates c-Myc and CDKN1A expression in breast cancer cells: β-CATENIN REGULATES c-Myc AND CDKN1A

Suchergebnisse filtern